Pancreatitis, Acute Clinical Trials

14 recruitingLast updated: May 21, 2026

There are 14 actively recruiting pancreatitis, acute clinical trials across 9 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 4. Top locations include Rochester, Minnesota, United States, Baotou, China, Beijing, China. Updated daily from ClinicalTrials.gov.


Pancreatitis, Acute Trials at a Glance

14 actively recruiting trials for pancreatitis, acute are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Rochester, Baotou, and Beijing. Lead sponsors running pancreatitis, acute studies include Mayo Clinic, Changhai Hospital, and Branislav Kuncak.

Browse pancreatitis, acute trials by phase

About Pancreatitis, Acute Clinical Trials

Looking for clinical trials for Pancreatitis, Acute? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pancreatitis, Acute trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pancreatitis, Acute clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy

Pancreatitis, ChronicPancreatitis, AcutePancreatic Duct Stones
Changhai Hospital1,250 enrolled10 locationsNCT07202559
Recruiting
Not Applicable

Efferon LPS Hemoadsorption in Patients With Acute Pancreatitis

Pancreatitis, Acute
Efferon JSC150 enrolled8 locationsNCT07267169
Recruiting
Phase 2

Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus

Diabetes MellitusPancreatitis, ChronicPancreatitis, Acute
Mayo Clinic40 enrolled2 locationsNCT06729996
Recruiting

Post-ERCP Pancreatitis - Prophylactic Measures Implementation Study (PEP-PROMIS)

Pancreatitis, AcuteERCPProphylaxis
Branislav Kuncak1,000 enrolled1 locationNCT07244432
Recruiting
Phase 2

Corticosteroids to Treat Pancreatitis

PancreatitisHydrocortisonePancreatitis, Acute+1 more
Beth Israel Deaconess Medical Center86 enrolled1 locationNCT05160506
Recruiting
Not Applicable

Strategic Timing of Endoscopic Interventions in Infected Necrotizing Pancreatitis

Pancreatitis, Acute Necrotizing
Orlando Health, Inc.104 enrolled1 locationNCT07406698
Recruiting

Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety

PancreatectomyPancreatitis, AcuteHyperamylasemia
Technische Universität Dresden150 enrolled1 locationNCT06126601
Recruiting
Phase 2

Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis

Smoking (Tobacco) AddictionPancreatitis, ChronicRecurrent Acute Pancreatitis+1 more
Mayo Clinic45 enrolled1 locationNCT07171112
Recruiting

EUS-guided FNB-induced PANCREatitis Assessment

Pancreatitis, AcuteEUS Guided Biopsy
University of Tehran300 enrolled1 locationNCT07168863
Recruiting
Phase 4

Comparison of the Effectiveness of Paracetamol With Ibuprofen or Paracetamol With Metamizole in Treating Pain in Acute Pancreatitis in Children

PaediatricsPain, AcuteGastroenterology+4 more
Medical University of Warsaw78 enrolled1 locationNCT07024199
Recruiting
Phase 1Phase 2

Safety and Tolerability of Pirfenidone in Acute Pancreatitis

Pancreatitis, Acute
University of Alabama at Birmingham60 enrolled2 locationsNCT05350371
Recruiting
Not Applicable

Fasciotens to Treat an Open Abdomen - a Prospective Cohort Study

Pancreatitis, Acute NecrotizingIntraabdominal HypertensionAbdominal Compartment Syndrome+1 more
RWTH Aachen University15 enrolled1 locationNCT04033614
Recruiting
Not Applicable

Quick Large Balloon Dilatation for Removal of Large Bile Duct Stones (SHODBADI)

BleedingCholangitisPancreatitis, Acute
Helsinki University Central Hospital600 enrolled2 locationsNCT05061680
Recruiting
Not Applicable

Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis

Pancreatic PseudocystPancreatic Fluid CollectionWalled-off Necrosis+1 more
Tokyo University70 enrolled21 locationsNCT05451901